Why is Sampre Nutrition falling/rising?

As of 27-Jun, Sampre Nutritions Ltd is currently priced at 33.76, reflecting an increase of 0.66 or 1.99%. The stock has been on a positive trajectory, gaining for the last 12 consecutive days and achieving a remarkable 40.9% return during this period. In the past week, the stock has outperformed its sector by 1.38%, and over the last month, it has risen by 20.57%. However, despite these short-term gains, the company faces significant challenges, including operating losses and a high Debt to EBITDA ratio of 5.01 times, which indicates a low ability to service its debt. Additionally, the company reported negative earnings in its latest quarterly results, with a PAT of Rs -7.35 crore, contributing to a concerning overall performance with a year-to-date decline of 47.00%.
In the broader market context, while the Sensex has increased by 2.00% over the past week, Sampre Nutritions Ltd has significantly outperformed this benchmark with a 10.33% gain. However, it is important to note that the stock has underperformed over the longer term, with a staggering 43.85% decline over the past year, contrasting sharply with the Sensex's 6.08% increase. This disparity highlights the stock's volatility and the risks associated with its current valuation, especially given its weak long-term fundamental strength and negative EBITDA. The falling investor participation, as indicated by a 39.93% drop in delivery volume, further complicates the outlook for the stock, suggesting that while it may be experiencing short-term gains, the long-term prospects remain uncertain.